Latent TGF-β binding proteins (LTBPs) 1 and 3 differentially regulate transforming growth factor-β activity in malignant mesothelioma

Human Pathology

Volumn 42, Issue 2, 2011, Pages 269-278

  Vehviläinen, Piia ^a   Koli, Katri ^a   Myllärniemi, Marjukka ^a   Lindholm, Pamela ^a   Soini, Ylermi ^b,c   Salmenkivi, Kaisa ^a   Kinnula, Vuokko L ^a   Keski Oja, Jorma ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

LTBP; Mesothelioma; Stroma; TGF ; Tumor biopsy

Indexed keywords

ISOPROTEIN; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 1; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 3; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PLEURA MESOTHELIOMA; PROTEIN EXPRESSION; PROTEIN SECRETION;

CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION; GENE SILENCING; HUMANS; KAPLAN-MEIER ESTIMATE; LATENT TGF-BETA BINDING PROTEINS; MESOTHELIOMA; PLEURAL NEOPLASMS; RNA, MESSENGER; RNA, SMALL INTERFERING; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 78751582141     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.07.005     Document Type: Article

References (39)

1. Jaurand M.C., and Fleury-Feith J. Pathogenesis of malignant pleural mesothelioma Respirology 10 2005 2 8
2. Kinnula V.L., Linnala A., Viitala E., Linnainmaa K., and Virtanen I. Tenascin and fibronectin expression in human mesothelial cells and pleural mesothelioma cell-line cells Am J Respir Cell Mol Biol 19 1998 445 452
3. Kaarteenaho-Wiik R., Soini Y., Pöllänen R., Pääkko P., and Kinnula V.L. Over-expression of tenascin-C in malignant pleural mesothelioma Histopathology 42 2003 280 291
4. Fitzpatrick D.R., Peroni D.J., and Bielefeldt-Ohmann H. The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma Am J Respir Cell Mol Biol 12 1995 455 460
5. Kumar-Singh S., Weyler J., Martin M.J., Vermeulen P.B., and Van Marck E. Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF-beta expression J Pathol 189 1999 72 78
6. Jagirdar J., Lee T.C., and Reibman J. Immunohistochemical localization of transforming growth factor-beta isoforms in asbestos-related diseases Environ Health Perspect 105 Suppl 5 1997 1197 1203
7. Gerwin B.I., Lechner J.F., and Reddel R.R. Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines Cancer Res 47 1987 6180 6184
8. Fitzpatrick D.R., Bielefeldt-Ohmann H., Himbeck R.P., Jarnicki A.G., Marzo A.L., and Robinson B.W. Transforming growth factor-beta: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and tumor-infiltrating T-cells in malignant mesothelioma Growth Factors 11 1994 29 44
9. Kuwahara M., Takeda M., Takeuchi Y., Harada T., and Maita K. Transforming growth factor beta production by spontaneous malignant mesothelioma cell lines derived from Fisher 344 rats Virchows Arch 438 2001 492 497
10. Bhowmick N.A., Neilson E.G., and Moses H.L. Stromal fibroblasts in cancer initiation and progression Nature 432 2004 332 337
11. Miyazono K., Olofsson A., Colosetti P., and Heldin C.H. A role of the latent TGF-beta1-binding protein in the assembly and secretion of TGF-beta 1 EMBO J 10 1991 1091 1101
12. Taipale J., Miyazono K., Heldin C.H., and Keski-Oja J. Latent transforming growth factor-beta1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein J Cell Biol 124 1994 171 181
13. Annes J.P., Munger J.S., and Rifkin D.B. Making sense of latent TGF-beta activation J Cell Sci 116 2003 217 224
14. Hyytiäinen M., Penttinen C., and Keski-Oja J. Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation Crit Rev Clin Lab Sci 41 2004 233 264
15. Saharinen J., and Keski-Oja J. Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta Mol Biol Cell 11 2000 2691 2704
16. Annes J.P., Chen Y., Munger J.S., and Rifkin D.B. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1 J Cell Biol 165 2004 723 734
17. Pelin-Enlund K., Husgafvel-Pursiainen K., and Tammilehto L. Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients Carcinogenesis 11 1990 673 681
18. Lindholm P.M., Soini Y., and Myllärniemi M. Expression of GATA-6 transcription factor in pleural malignant mesothelioma and metastatic pulmonary adenocarcinoma J Clin Pathol 62 2009 339 344
19. Abe M., Harpel J.G., Metz C.N., Nunes I., Loskutoff D.J., and Rifkin D.B. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct Anal Biochem 216 1994 276 284
20. Attisano L., and Wrana J.L. Signal transduction by members of the transforming growth factor-beta superfamily Cytokine Growth Factor Rev 7 1996 327 339
21. Attisano L., and Wrana J.L. Signal transduction by the TGF-beta superfamily Science 296 2002 1646 1647
22. Maeda J., Ueki N., and Ohkawa T. Transforming growth factor-beta1 (TGF-beta1) and -beta2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer Clin Exp Immunol 98 1994 319 322
23. DeLong P., Carroll R.G., and Henry A.C. Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma Cancer Biol Ther 4 2005 342 346
24. Gabrielson E.W., Gerwin B.I., Harris C.C., Roberts A.B., Sporn M.B., and Lechner J.F. Stimulation of DNA synthesis in cultured primary human mesothelial cells by specific growth factors FASEB J 2 1988 2717 2721
25. Marzo A.L., Fitzpatrick D.R., Robinson B.W., and Scott B. Antisense oligonucleotides specific for transforming growth factor-beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivo Cancer Res 57 1997 3200 3207
26. Suzuki E., Kapoor V., and Cheung H.K. Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity Clin Cancer Res 10 2004 5907 5918
27. Suzuki E., Kim S., and Cheung H.K. A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection Cancer Res 67 2007 2351 2359
28. Eklöv S., Funa K., and Nordgren H. Lack of the latent transforming growth factor-beta binding protein in malignant, but not benign prostatic tissue Cancer Res 53 1993 3193 3197
29. Penttinen C., Saharinen J., Weikkolainen K., Hyytiäinen M., and Keski-Oja J. Secretion of human latent TGF-beta binding protein-3 (LTBP-3) is dependent on co-expression of TGF-beta J Cell Sci 115 2002 3457 3468
30. Bonewald L.F., Wakefield L., Oreffo R.O., Escobedo A., Twardzik D.R., and Mundy G.R. Latent forms of transforming growth factor-beta (TGF beta) derived from bone cultures: identification of a naturally occurring 100-kDa complex with similarity to recombinant latent TGF-beta Mol Endocrinol 5 1991 741 751
31. Olofsson A., Miyazono K., Kanzaki T., Colosetti P., Engstrom U., and Heldin C.H. Transforming growth factor-beta1, -beta2, and -beta3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes J Biol Chem 267 1992 19482 19488
32. Mazzieri R., Jurukovski V., and Obata H. Expression of truncated latent TGF-beta-binding protein modulates TGF-beta signaling J Cell Sci 118 2005 2177 2187
33. Neptune E.R., Frischmeyer P.A., and Arking D.E. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome Nat Genet 33 2003 407 411
34. Koli K., Ryynänen M.J., and Keski-Oja J. Latent TGF-beta binding proteins (LTBPs)-1 and -3 coordinate proliferation and osteogenic differentiation of human mesenchymal stem cells Bone 43 2008 679 688
35. Zhong J., Gencay M.M., and Bubendorf L. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells J Cell Physiol 207 2006 540 552
36. Mizoi T., Ohtani H., Miyazono K., Miyazawa M., Matsuno S., and Nagura H. Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor-beta1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells Cancer Res 53 1993 183 190
37. Weikkolainen K., Keski-Oja J., and Koli K. Expression of latent TGF-beta binding protein LTBP-1 is hormonally regulated in normal and transformed human lung fibroblasts Growth Factors 21 2003 51 60
38. De Wever O., Demetter P., Mareel M., and Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth Int J Cancer 123 2008 2229 2238
39. Nasreen N., Mohammed K.A., and Mubarak K.K. Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro Am J Physiol Lung Cell Mol Physiol 297 2009 L115 L124